1. INTRODUCTION
More than two years after the appearance of coronavirus disease 2019 (COVID-19), the relevant research is still ongoing. COVID-19 can lead to hemostatic disorders and thrombotic diseases due to exaggerated inflammatory process, decreased tissue oxygenation, and endothelial dysfunction [1].
Intracardiac thrombi, including tricuspid valve thrombus (TVT), are very rare life-threatening complications of COVID-19 which indicate high index of suspicion to provide early proper management [2, 3]. Herein, we report a surgically treated patient with TVT associated with moderate-to-severe tricuspid regurgitation (TR) during the course of COVID-19 pneumonia.